Global Pain Reliever Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Pain Reliever Industry Forecast” looks at past sales and reviews total world Pain Reliever sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Reliever sales for 2023 through 2029. With Pain Reliever sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pain Reliever industry.
This Insight Report provides a comprehensive analysis of the global Pain Reliever landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pain Reliever portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pain Reliever market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pain Reliever and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pain Reliever.
The global Pain Reliever market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pain Reliever players cover Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pain Reliever market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pain Reliever market?
What factors are driving Pain Reliever market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pain Reliever market opportunities vary by end market size?
How does Pain Reliever break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Pain Reliever Industry Forecast” looks at past sales and reviews total world Pain Reliever sales in 2022, providing a comprehensive analysis by region and market sector of projected Pain Reliever sales for 2023 through 2029. With Pain Reliever sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pain Reliever industry.
This Insight Report provides a comprehensive analysis of the global Pain Reliever landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pain Reliever portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pain Reliever market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pain Reliever and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pain Reliever.
The global Pain Reliever market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pain Reliever is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pain Reliever players cover Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pain Reliever market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Generic Opioids
- Branded Opioids
- NSAIDs
- Others
- Hospitals
- Clinics
- Drugstores
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Endo
- Merck
- Depomed
- Yunnan Baiyao
- Teva
- J&J
- Allergan
- Purdue
What is the 10-year outlook for the global Pain Reliever market?
What factors are driving Pain Reliever market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pain Reliever market opportunities vary by end market size?
How does Pain Reliever break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pain Reliever Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pain Reliever by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pain Reliever by Country/Region, 2018, 2022 & 2029
2.2 Pain Reliever Segment by Type
2.2.1 Generic Opioids
2.2.2 Branded Opioids
2.2.3 NSAIDs
2.2.4 Others
2.3 Pain Reliever Sales by Type
2.3.1 Global Pain Reliever Sales Market Share by Type (2018-2023)
2.3.2 Global Pain Reliever Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pain Reliever Sale Price by Type (2018-2023)
2.4 Pain Reliever Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.5 Pain Reliever Sales by Application
2.5.1 Global Pain Reliever Sale Market Share by Application (2018-2023)
2.5.2 Global Pain Reliever Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pain Reliever Sale Price by Application (2018-2023)
3 GLOBAL PAIN RELIEVER BY COMPANY
3.1 Global Pain Reliever Breakdown Data by Company
3.1.1 Global Pain Reliever Annual Sales by Company (2018-2023)
3.1.2 Global Pain Reliever Sales Market Share by Company (2018-2023)
3.2 Global Pain Reliever Annual Revenue by Company (2018-2023)
3.2.1 Global Pain Reliever Revenue by Company (2018-2023)
3.2.2 Global Pain Reliever Revenue Market Share by Company (2018-2023)
3.3 Global Pain Reliever Sale Price by Company
3.4 Key Manufacturers Pain Reliever Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pain Reliever Product Location Distribution
3.4.2 Players Pain Reliever Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PAIN RELIEVER BY GEOGRAPHIC REGION
4.1 World Historic Pain Reliever Market Size by Geographic Region (2018-2023)
4.1.1 Global Pain Reliever Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pain Reliever Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pain Reliever Market Size by Country/Region (2018-2023)
4.2.1 Global Pain Reliever Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pain Reliever Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pain Reliever Sales Growth
4.4 APAC Pain Reliever Sales Growth
4.5 Europe Pain Reliever Sales Growth
4.6 Middle East & Africa Pain Reliever Sales Growth
5 AMERICAS
5.1 Americas Pain Reliever Sales by Country
5.1.1 Americas Pain Reliever Sales by Country (2018-2023)
5.1.2 Americas Pain Reliever Revenue by Country (2018-2023)
5.2 Americas Pain Reliever Sales by Type
5.3 Americas Pain Reliever Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pain Reliever Sales by Region
6.1.1 APAC Pain Reliever Sales by Region (2018-2023)
6.1.2 APAC Pain Reliever Revenue by Region (2018-2023)
6.2 APAC Pain Reliever Sales by Type
6.3 APAC Pain Reliever Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pain Reliever by Country
7.1.1 Europe Pain Reliever Sales by Country (2018-2023)
7.1.2 Europe Pain Reliever Revenue by Country (2018-2023)
7.2 Europe Pain Reliever Sales by Type
7.3 Europe Pain Reliever Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pain Reliever by Country
8.1.1 Middle East & Africa Pain Reliever Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pain Reliever Revenue by Country (2018-2023)
8.2 Middle East & Africa Pain Reliever Sales by Type
8.3 Middle East & Africa Pain Reliever Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pain Reliever
10.3 Manufacturing Process Analysis of Pain Reliever
10.4 Industry Chain Structure of Pain Reliever
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pain Reliever Distributors
11.3 Pain Reliever Customer
12 WORLD FORECAST REVIEW FOR PAIN RELIEVER BY GEOGRAPHIC REGION
12.1 Global Pain Reliever Market Size Forecast by Region
12.1.1 Global Pain Reliever Forecast by Region (2024-2029)
12.1.2 Global Pain Reliever Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pain Reliever Forecast by Type
12.7 Global Pain Reliever Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pain Reliever Product Portfolios and Specifications
13.1.3 Pfizer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pain Reliever Product Portfolios and Specifications
13.2.3 GSK Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Grunenthal
13.3.1 Grunenthal Company Information
13.3.2 Grunenthal Pain Reliever Product Portfolios and Specifications
13.3.3 Grunenthal Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grunenthal Main Business Overview
13.3.5 Grunenthal Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Pain Reliever Product Portfolios and Specifications
13.4.3 Bayer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Pain Reliever Product Portfolios and Specifications
13.5.3 Sanofi Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Pain Reliever Product Portfolios and Specifications
13.6.3 Eli Lilly Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Pain Reliever Product Portfolios and Specifications
13.7.3 AstraZeneca Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo Pain Reliever Product Portfolios and Specifications
13.8.3 Endo Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Pain Reliever Product Portfolios and Specifications
13.9.3 Merck Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Depomed
13.10.1 Depomed Company Information
13.10.2 Depomed Pain Reliever Product Portfolios and Specifications
13.10.3 Depomed Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Depomed Main Business Overview
13.10.5 Depomed Latest Developments
13.11 Yunnan Baiyao
13.11.1 Yunnan Baiyao Company Information
13.11.2 Yunnan Baiyao Pain Reliever Product Portfolios and Specifications
13.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yunnan Baiyao Main Business Overview
13.11.5 Yunnan Baiyao Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Pain Reliever Product Portfolios and Specifications
13.12.3 Teva Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 J&J
13.13.1 J&J Company Information
13.13.2 J&J Pain Reliever Product Portfolios and Specifications
13.13.3 J&J Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 J&J Main Business Overview
13.13.5 J&J Latest Developments
13.14 Allergan
13.14.1 Allergan Company Information
13.14.2 Allergan Pain Reliever Product Portfolios and Specifications
13.14.3 Allergan Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Allergan Main Business Overview
13.14.5 Allergan Latest Developments
13.15 Purdue
13.15.1 Purdue Company Information
13.15.2 Purdue Pain Reliever Product Portfolios and Specifications
13.15.3 Purdue Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Purdue Main Business Overview
13.15.5 Purdue Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pain Reliever Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pain Reliever by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pain Reliever by Country/Region, 2018, 2022 & 2029
2.2 Pain Reliever Segment by Type
2.2.1 Generic Opioids
2.2.2 Branded Opioids
2.2.3 NSAIDs
2.2.4 Others
2.3 Pain Reliever Sales by Type
2.3.1 Global Pain Reliever Sales Market Share by Type (2018-2023)
2.3.2 Global Pain Reliever Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pain Reliever Sale Price by Type (2018-2023)
2.4 Pain Reliever Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drugstores
2.5 Pain Reliever Sales by Application
2.5.1 Global Pain Reliever Sale Market Share by Application (2018-2023)
2.5.2 Global Pain Reliever Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pain Reliever Sale Price by Application (2018-2023)
3 GLOBAL PAIN RELIEVER BY COMPANY
3.1 Global Pain Reliever Breakdown Data by Company
3.1.1 Global Pain Reliever Annual Sales by Company (2018-2023)
3.1.2 Global Pain Reliever Sales Market Share by Company (2018-2023)
3.2 Global Pain Reliever Annual Revenue by Company (2018-2023)
3.2.1 Global Pain Reliever Revenue by Company (2018-2023)
3.2.2 Global Pain Reliever Revenue Market Share by Company (2018-2023)
3.3 Global Pain Reliever Sale Price by Company
3.4 Key Manufacturers Pain Reliever Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pain Reliever Product Location Distribution
3.4.2 Players Pain Reliever Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PAIN RELIEVER BY GEOGRAPHIC REGION
4.1 World Historic Pain Reliever Market Size by Geographic Region (2018-2023)
4.1.1 Global Pain Reliever Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pain Reliever Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pain Reliever Market Size by Country/Region (2018-2023)
4.2.1 Global Pain Reliever Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pain Reliever Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pain Reliever Sales Growth
4.4 APAC Pain Reliever Sales Growth
4.5 Europe Pain Reliever Sales Growth
4.6 Middle East & Africa Pain Reliever Sales Growth
5 AMERICAS
5.1 Americas Pain Reliever Sales by Country
5.1.1 Americas Pain Reliever Sales by Country (2018-2023)
5.1.2 Americas Pain Reliever Revenue by Country (2018-2023)
5.2 Americas Pain Reliever Sales by Type
5.3 Americas Pain Reliever Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pain Reliever Sales by Region
6.1.1 APAC Pain Reliever Sales by Region (2018-2023)
6.1.2 APAC Pain Reliever Revenue by Region (2018-2023)
6.2 APAC Pain Reliever Sales by Type
6.3 APAC Pain Reliever Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pain Reliever by Country
7.1.1 Europe Pain Reliever Sales by Country (2018-2023)
7.1.2 Europe Pain Reliever Revenue by Country (2018-2023)
7.2 Europe Pain Reliever Sales by Type
7.3 Europe Pain Reliever Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pain Reliever by Country
8.1.1 Middle East & Africa Pain Reliever Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pain Reliever Revenue by Country (2018-2023)
8.2 Middle East & Africa Pain Reliever Sales by Type
8.3 Middle East & Africa Pain Reliever Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pain Reliever
10.3 Manufacturing Process Analysis of Pain Reliever
10.4 Industry Chain Structure of Pain Reliever
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pain Reliever Distributors
11.3 Pain Reliever Customer
12 WORLD FORECAST REVIEW FOR PAIN RELIEVER BY GEOGRAPHIC REGION
12.1 Global Pain Reliever Market Size Forecast by Region
12.1.1 Global Pain Reliever Forecast by Region (2024-2029)
12.1.2 Global Pain Reliever Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pain Reliever Forecast by Type
12.7 Global Pain Reliever Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pain Reliever Product Portfolios and Specifications
13.1.3 Pfizer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pain Reliever Product Portfolios and Specifications
13.2.3 GSK Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Grunenthal
13.3.1 Grunenthal Company Information
13.3.2 Grunenthal Pain Reliever Product Portfolios and Specifications
13.3.3 Grunenthal Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grunenthal Main Business Overview
13.3.5 Grunenthal Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Pain Reliever Product Portfolios and Specifications
13.4.3 Bayer Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Pain Reliever Product Portfolios and Specifications
13.5.3 Sanofi Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Eli Lilly
13.6.1 Eli Lilly Company Information
13.6.2 Eli Lilly Pain Reliever Product Portfolios and Specifications
13.6.3 Eli Lilly Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Eli Lilly Main Business Overview
13.6.5 Eli Lilly Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Pain Reliever Product Portfolios and Specifications
13.7.3 AstraZeneca Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Endo
13.8.1 Endo Company Information
13.8.2 Endo Pain Reliever Product Portfolios and Specifications
13.8.3 Endo Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Endo Main Business Overview
13.8.5 Endo Latest Developments
13.9 Merck
13.9.1 Merck Company Information
13.9.2 Merck Pain Reliever Product Portfolios and Specifications
13.9.3 Merck Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Merck Main Business Overview
13.9.5 Merck Latest Developments
13.10 Depomed
13.10.1 Depomed Company Information
13.10.2 Depomed Pain Reliever Product Portfolios and Specifications
13.10.3 Depomed Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Depomed Main Business Overview
13.10.5 Depomed Latest Developments
13.11 Yunnan Baiyao
13.11.1 Yunnan Baiyao Company Information
13.11.2 Yunnan Baiyao Pain Reliever Product Portfolios and Specifications
13.11.3 Yunnan Baiyao Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yunnan Baiyao Main Business Overview
13.11.5 Yunnan Baiyao Latest Developments
13.12 Teva
13.12.1 Teva Company Information
13.12.2 Teva Pain Reliever Product Portfolios and Specifications
13.12.3 Teva Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Teva Main Business Overview
13.12.5 Teva Latest Developments
13.13 J&J
13.13.1 J&J Company Information
13.13.2 J&J Pain Reliever Product Portfolios and Specifications
13.13.3 J&J Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 J&J Main Business Overview
13.13.5 J&J Latest Developments
13.14 Allergan
13.14.1 Allergan Company Information
13.14.2 Allergan Pain Reliever Product Portfolios and Specifications
13.14.3 Allergan Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Allergan Main Business Overview
13.14.5 Allergan Latest Developments
13.15 Purdue
13.15.1 Purdue Company Information
13.15.2 Purdue Pain Reliever Product Portfolios and Specifications
13.15.3 Purdue Pain Reliever Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Purdue Main Business Overview
13.15.5 Purdue Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pain Reliever Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pain Reliever Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic Opioids
Table 4. Major Players of Branded Opioids
Table 5. Major Players of NSAIDs
Table 6. Major Players of Others
Table 7. Global Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 8. Global Pain Reliever Sales Market Share by Type (2018-2023)
Table 9. Global Pain Reliever Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pain Reliever Revenue Market Share by Type (2018-2023)
Table 11. Global Pain Reliever Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 13. Global Pain Reliever Sales Market Share by Application (2018-2023)
Table 14. Global Pain Reliever Revenue by Application (2018-2023)
Table 15. Global Pain Reliever Revenue Market Share by Application (2018-2023)
Table 16. Global Pain Reliever Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Pain Reliever Sales by Company (2018-2023) & (K Units)
Table 18. Global Pain Reliever Sales Market Share by Company (2018-2023)
Table 19. Global Pain Reliever Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pain Reliever Revenue Market Share by Company (2018-2023)
Table 21. Global Pain Reliever Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Pain Reliever Producing Area Distribution and Sales Area
Table 23. Players Pain Reliever Products Offered
Table 24. Pain Reliever Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pain Reliever Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Pain Reliever Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pain Reliever Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pain Reliever Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pain Reliever Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Pain Reliever Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pain Reliever Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pain Reliever Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 36. Americas Pain Reliever Sales Market Share by Country (2018-2023)
Table 37. Americas Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pain Reliever Revenue Market Share by Country (2018-2023)
Table 39. Americas Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 40. Americas Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 41. APAC Pain Reliever Sales by Region (2018-2023) & (K Units)
Table 42. APAC Pain Reliever Sales Market Share by Region (2018-2023)
Table 43. APAC Pain Reliever Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pain Reliever Revenue Market Share by Region (2018-2023)
Table 45. APAC Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 46. APAC Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 47. Europe Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 48. Europe Pain Reliever Sales Market Share by Country (2018-2023)
Table 49. Europe Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pain Reliever Revenue Market Share by Country (2018-2023)
Table 51. Europe Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 52. Europe Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Pain Reliever Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pain Reliever Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Pain Reliever
Table 60. Key Market Challenges & Risks of Pain Reliever
Table 61. Key Industry Trends of Pain Reliever
Table 62. Pain Reliever Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pain Reliever Distributors List
Table 65. Pain Reliever Customer List
Table 66. Global Pain Reliever Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Pain Reliever Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pain Reliever Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Pain Reliever Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pain Reliever Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Pain Reliever Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pain Reliever Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Pain Reliever Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Pfizer Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Pain Reliever Product Portfolios and Specifications
Table 82. Pfizer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. GSK Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Pain Reliever Product Portfolios and Specifications
Table 87. GSK Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Grunenthal Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 91. Grunenthal Pain Reliever Product Portfolios and Specifications
Table 92. Grunenthal Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Grunenthal Main Business
Table 94. Grunenthal Latest Developments
Table 95. Bayer Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer Pain Reliever Product Portfolios and Specifications
Table 97. Bayer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. Sanofi Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Pain Reliever Product Portfolios and Specifications
Table 102. Sanofi Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Eli Lilly Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 106. Eli Lilly Pain Reliever Product Portfolios and Specifications
Table 107. Eli Lilly Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Eli Lilly Main Business
Table 109. Eli Lilly Latest Developments
Table 110. AstraZeneca Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 111. AstraZeneca Pain Reliever Product Portfolios and Specifications
Table 112. AstraZeneca Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AstraZeneca Main Business
Table 114. AstraZeneca Latest Developments
Table 115. Endo Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 116. Endo Pain Reliever Product Portfolios and Specifications
Table 117. Endo Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Endo Main Business
Table 119. Endo Latest Developments
Table 120. Merck Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 121. Merck Pain Reliever Product Portfolios and Specifications
Table 122. Merck Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck Main Business
Table 124. Merck Latest Developments
Table 125. Depomed Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 126. Depomed Pain Reliever Product Portfolios and Specifications
Table 127. Depomed Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Depomed Main Business
Table 129. Depomed Latest Developments
Table 130. Yunnan Baiyao Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 131. Yunnan Baiyao Pain Reliever Product Portfolios and Specifications
Table 132. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Yunnan Baiyao Main Business
Table 134. Yunnan Baiyao Latest Developments
Table 135. Teva Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pain Reliever Product Portfolios and Specifications
Table 137. Teva Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Teva Main Business
Table 139. Teva Latest Developments
Table 140. J&J Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 141. J&J Pain Reliever Product Portfolios and Specifications
Table 142. J&J Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. J&J Main Business
Table 144. J&J Latest Developments
Table 145. Allergan Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 146. Allergan Pain Reliever Product Portfolios and Specifications
Table 147. Allergan Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Allergan Main Business
Table 149. Allergan Latest Developments
Table 150. Purdue Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pain Reliever Product Portfolios and Specifications
Table 152. Purdue Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Purdue Main Business
Table 154. Purdue Latest Developments
Table 1. Pain Reliever Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pain Reliever Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Generic Opioids
Table 4. Major Players of Branded Opioids
Table 5. Major Players of NSAIDs
Table 6. Major Players of Others
Table 7. Global Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 8. Global Pain Reliever Sales Market Share by Type (2018-2023)
Table 9. Global Pain Reliever Revenue by Type (2018-2023) & ($ million)
Table 10. Global Pain Reliever Revenue Market Share by Type (2018-2023)
Table 11. Global Pain Reliever Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 13. Global Pain Reliever Sales Market Share by Application (2018-2023)
Table 14. Global Pain Reliever Revenue by Application (2018-2023)
Table 15. Global Pain Reliever Revenue Market Share by Application (2018-2023)
Table 16. Global Pain Reliever Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Pain Reliever Sales by Company (2018-2023) & (K Units)
Table 18. Global Pain Reliever Sales Market Share by Company (2018-2023)
Table 19. Global Pain Reliever Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Pain Reliever Revenue Market Share by Company (2018-2023)
Table 21. Global Pain Reliever Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Pain Reliever Producing Area Distribution and Sales Area
Table 23. Players Pain Reliever Products Offered
Table 24. Pain Reliever Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Pain Reliever Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Pain Reliever Sales Market Share Geographic Region (2018-2023)
Table 29. Global Pain Reliever Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Pain Reliever Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Pain Reliever Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Pain Reliever Sales Market Share by Country/Region (2018-2023)
Table 33. Global Pain Reliever Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Pain Reliever Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 36. Americas Pain Reliever Sales Market Share by Country (2018-2023)
Table 37. Americas Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Pain Reliever Revenue Market Share by Country (2018-2023)
Table 39. Americas Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 40. Americas Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 41. APAC Pain Reliever Sales by Region (2018-2023) & (K Units)
Table 42. APAC Pain Reliever Sales Market Share by Region (2018-2023)
Table 43. APAC Pain Reliever Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Pain Reliever Revenue Market Share by Region (2018-2023)
Table 45. APAC Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 46. APAC Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 47. Europe Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 48. Europe Pain Reliever Sales Market Share by Country (2018-2023)
Table 49. Europe Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Pain Reliever Revenue Market Share by Country (2018-2023)
Table 51. Europe Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 52. Europe Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Pain Reliever Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Pain Reliever Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pain Reliever Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Pain Reliever Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Pain Reliever Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Pain Reliever Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Pain Reliever
Table 60. Key Market Challenges & Risks of Pain Reliever
Table 61. Key Industry Trends of Pain Reliever
Table 62. Pain Reliever Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Pain Reliever Distributors List
Table 65. Pain Reliever Customer List
Table 66. Global Pain Reliever Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Pain Reliever Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Pain Reliever Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Pain Reliever Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Pain Reliever Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Pain Reliever Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Pain Reliever Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Pain Reliever Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Pain Reliever Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Pain Reliever Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Pfizer Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer Pain Reliever Product Portfolios and Specifications
Table 82. Pfizer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. GSK Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Pain Reliever Product Portfolios and Specifications
Table 87. GSK Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Grunenthal Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 91. Grunenthal Pain Reliever Product Portfolios and Specifications
Table 92. Grunenthal Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Grunenthal Main Business
Table 94. Grunenthal Latest Developments
Table 95. Bayer Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 96. Bayer Pain Reliever Product Portfolios and Specifications
Table 97. Bayer Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Bayer Main Business
Table 99. Bayer Latest Developments
Table 100. Sanofi Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 101. Sanofi Pain Reliever Product Portfolios and Specifications
Table 102. Sanofi Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Main Business
Table 104. Sanofi Latest Developments
Table 105. Eli Lilly Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 106. Eli Lilly Pain Reliever Product Portfolios and Specifications
Table 107. Eli Lilly Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Eli Lilly Main Business
Table 109. Eli Lilly Latest Developments
Table 110. AstraZeneca Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 111. AstraZeneca Pain Reliever Product Portfolios and Specifications
Table 112. AstraZeneca Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AstraZeneca Main Business
Table 114. AstraZeneca Latest Developments
Table 115. Endo Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 116. Endo Pain Reliever Product Portfolios and Specifications
Table 117. Endo Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Endo Main Business
Table 119. Endo Latest Developments
Table 120. Merck Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 121. Merck Pain Reliever Product Portfolios and Specifications
Table 122. Merck Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Merck Main Business
Table 124. Merck Latest Developments
Table 125. Depomed Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 126. Depomed Pain Reliever Product Portfolios and Specifications
Table 127. Depomed Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Depomed Main Business
Table 129. Depomed Latest Developments
Table 130. Yunnan Baiyao Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 131. Yunnan Baiyao Pain Reliever Product Portfolios and Specifications
Table 132. Yunnan Baiyao Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Yunnan Baiyao Main Business
Table 134. Yunnan Baiyao Latest Developments
Table 135. Teva Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 136. Teva Pain Reliever Product Portfolios and Specifications
Table 137. Teva Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Teva Main Business
Table 139. Teva Latest Developments
Table 140. J&J Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 141. J&J Pain Reliever Product Portfolios and Specifications
Table 142. J&J Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. J&J Main Business
Table 144. J&J Latest Developments
Table 145. Allergan Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 146. Allergan Pain Reliever Product Portfolios and Specifications
Table 147. Allergan Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Allergan Main Business
Table 149. Allergan Latest Developments
Table 150. Purdue Basic Information, Pain Reliever Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pain Reliever Product Portfolios and Specifications
Table 152. Purdue Pain Reliever Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Purdue Main Business
Table 154. Purdue Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pain Reliever
Figure 2. Pain Reliever Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pain Reliever Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pain Reliever Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pain Reliever Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic Opioids
Figure 10. Product Picture of Branded Opioids
Figure 11. Product Picture of NSAIDs
Figure 12. Product Picture of Others
Figure 13. Global Pain Reliever Sales Market Share by Type in 2022
Figure 14. Global Pain Reliever Revenue Market Share by Type (2018-2023)
Figure 15. Pain Reliever Consumed in Hospitals
Figure 16. Global Pain Reliever Market: Hospitals (2018-2023) & (K Units)
Figure 17. Pain Reliever Consumed in Clinics
Figure 18. Global Pain Reliever Market: Clinics (2018-2023) & (K Units)
Figure 19. Pain Reliever Consumed in Drugstores
Figure 20. Global Pain Reliever Market: Drugstores (2018-2023) & (K Units)
Figure 21. Global Pain Reliever Sales Market Share by Application (2022)
Figure 22. Global Pain Reliever Revenue Market Share by Application in 2022
Figure 23. Pain Reliever Sales Market by Company in 2022 (K Units)
Figure 24. Global Pain Reliever Sales Market Share by Company in 2022
Figure 25. Pain Reliever Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Pain Reliever Revenue Market Share by Company in 2022
Figure 27. Global Pain Reliever Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Pain Reliever Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Pain Reliever Sales 2018-2023 (K Units)
Figure 30. Americas Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 31. APAC Pain Reliever Sales 2018-2023 (K Units)
Figure 32. APAC Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 33. Europe Pain Reliever Sales 2018-2023 (K Units)
Figure 34. Europe Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Pain Reliever Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 37. Americas Pain Reliever Sales Market Share by Country in 2022
Figure 38. Americas Pain Reliever Revenue Market Share by Country in 2022
Figure 39. Americas Pain Reliever Sales Market Share by Type (2018-2023)
Figure 40. Americas Pain Reliever Sales Market Share by Application (2018-2023)
Figure 41. United States Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Pain Reliever Sales Market Share by Region in 2022
Figure 46. APAC Pain Reliever Revenue Market Share by Regions in 2022
Figure 47. APAC Pain Reliever Sales Market Share by Type (2018-2023)
Figure 48. APAC Pain Reliever Sales Market Share by Application (2018-2023)
Figure 49. China Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Pain Reliever Sales Market Share by Country in 2022
Figure 57. Europe Pain Reliever Revenue Market Share by Country in 2022
Figure 58. Europe Pain Reliever Sales Market Share by Type (2018-2023)
Figure 59. Europe Pain Reliever Sales Market Share by Application (2018-2023)
Figure 60. Germany Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Pain Reliever Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Pain Reliever Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Pain Reliever Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Pain Reliever Sales Market Share by Application (2018-2023)
Figure 69. Egypt Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Pain Reliever in 2022
Figure 75. Manufacturing Process Analysis of Pain Reliever
Figure 76. Industry Chain Structure of Pain Reliever
Figure 77. Channels of Distribution
Figure 78. Global Pain Reliever Sales Market Forecast by Region (2024-2029)
Figure 79. Global Pain Reliever Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Pain Reliever Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Pain Reliever Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Pain Reliever Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Pain Reliever Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pain Reliever
Figure 2. Pain Reliever Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pain Reliever Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pain Reliever Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pain Reliever Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Generic Opioids
Figure 10. Product Picture of Branded Opioids
Figure 11. Product Picture of NSAIDs
Figure 12. Product Picture of Others
Figure 13. Global Pain Reliever Sales Market Share by Type in 2022
Figure 14. Global Pain Reliever Revenue Market Share by Type (2018-2023)
Figure 15. Pain Reliever Consumed in Hospitals
Figure 16. Global Pain Reliever Market: Hospitals (2018-2023) & (K Units)
Figure 17. Pain Reliever Consumed in Clinics
Figure 18. Global Pain Reliever Market: Clinics (2018-2023) & (K Units)
Figure 19. Pain Reliever Consumed in Drugstores
Figure 20. Global Pain Reliever Market: Drugstores (2018-2023) & (K Units)
Figure 21. Global Pain Reliever Sales Market Share by Application (2022)
Figure 22. Global Pain Reliever Revenue Market Share by Application in 2022
Figure 23. Pain Reliever Sales Market by Company in 2022 (K Units)
Figure 24. Global Pain Reliever Sales Market Share by Company in 2022
Figure 25. Pain Reliever Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Pain Reliever Revenue Market Share by Company in 2022
Figure 27. Global Pain Reliever Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Pain Reliever Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Pain Reliever Sales 2018-2023 (K Units)
Figure 30. Americas Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 31. APAC Pain Reliever Sales 2018-2023 (K Units)
Figure 32. APAC Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 33. Europe Pain Reliever Sales 2018-2023 (K Units)
Figure 34. Europe Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Pain Reliever Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Pain Reliever Revenue 2018-2023 ($ Millions)
Figure 37. Americas Pain Reliever Sales Market Share by Country in 2022
Figure 38. Americas Pain Reliever Revenue Market Share by Country in 2022
Figure 39. Americas Pain Reliever Sales Market Share by Type (2018-2023)
Figure 40. Americas Pain Reliever Sales Market Share by Application (2018-2023)
Figure 41. United States Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Pain Reliever Sales Market Share by Region in 2022
Figure 46. APAC Pain Reliever Revenue Market Share by Regions in 2022
Figure 47. APAC Pain Reliever Sales Market Share by Type (2018-2023)
Figure 48. APAC Pain Reliever Sales Market Share by Application (2018-2023)
Figure 49. China Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Pain Reliever Sales Market Share by Country in 2022
Figure 57. Europe Pain Reliever Revenue Market Share by Country in 2022
Figure 58. Europe Pain Reliever Sales Market Share by Type (2018-2023)
Figure 59. Europe Pain Reliever Sales Market Share by Application (2018-2023)
Figure 60. Germany Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Pain Reliever Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Pain Reliever Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Pain Reliever Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Pain Reliever Sales Market Share by Application (2018-2023)
Figure 69. Egypt Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Pain Reliever Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Pain Reliever in 2022
Figure 75. Manufacturing Process Analysis of Pain Reliever
Figure 76. Industry Chain Structure of Pain Reliever
Figure 77. Channels of Distribution
Figure 78. Global Pain Reliever Sales Market Forecast by Region (2024-2029)
Figure 79. Global Pain Reliever Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Pain Reliever Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Pain Reliever Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Pain Reliever Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Pain Reliever Revenue Market Share Forecast by Application (2024-2029)
